Vialase releases data from study of Femtosecond Laser Image-Guided High-Revision Trabeculotomy
Vialase, a medical device company specializing in glaucoma treatment, has released data from a clinical study of their Femtosecond Laser Image-Guided High-Revision Trabeculotomy procedure. The study found that the procedure is safe and effective for patients with glaucoma who have failed previous surgeries. The procedure uses a femtosecond laser to create a precise incision in the eye, allowing for better access to the drainage system and improved fluid outflow, resulting in reduced intraocular pressure. This could potentially reduce the need for medication and further surgeries. The procedure has been approved for use in Europe and is currently in clinical trials in the United States.